# Therapeutic Equivalence of Diclofenac Sodium Gel 3% vs Solaraze ® in the Treatment of Actinic Keratosis

> **NCT03826550** · PHASE3 · COMPLETED · sponsor: **Encube Ethicals Pvt. Ltd.** · enrollment: 655 (actual)

## Conditions studied

- Actinic Keratoses

## Interventions

- **DRUG:** Diclofenac Sodium Gel
- **DRUG:** Solaraze 3% Topical Gel
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03826550
- **Lead sponsor:** Encube Ethicals Pvt. Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-12
- **Primary completion:** 2018-06-30
- **Final completion:** 2018-07-03
- **Target enrollment:** 655 (ACTUAL)
- **Last updated:** 2019-02-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03826550

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03826550, "Therapeutic Equivalence of Diclofenac Sodium Gel 3% vs Solaraze ® in the Treatment of Actinic Keratosis". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT03826550. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*